Emergent BioSolutions Balance Sheet Health
Financial Health criteria checks 2/6
Emergent BioSolutions has a total shareholder equity of $663.9M and total debt of $905.9M, which brings its debt-to-equity ratio to 136.5%. Its total assets and total liabilities are $1.8B and $1.1B respectively.
Key information
136.5%
Debt to equity ratio
US$905.90m
Debt
Interest coverage ratio | n/a |
Cash | US$78.50m |
Equity | US$663.90m |
Total liabilities | US$1.14b |
Total assets | US$1.80b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0IGA's short term assets ($682.4M) exceed its short term liabilities ($630.2M).
Long Term Liabilities: 0IGA's short term assets ($682.4M) exceed its long term liabilities ($509.5M).
Debt to Equity History and Analysis
Debt Level: 0IGA's net debt to equity ratio (124.6%) is considered high.
Reducing Debt: 0IGA's debt to equity ratio has increased from 75.2% to 136.5% over the past 5 years.
Debt Coverage: 0IGA's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 0IGA's interest payments on its debt are well covered by EBIT.